SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
1.370
+0.070 (5.38%)
Apr 23, 2025, 4:00 PM EDT - Market closed
SAB Biotherapeutics Market Cap
SAB Biotherapeutics has a market cap or net worth of $12.73 million as of April 23, 2025. Its market cap has decreased by -68.22% in one year.
Market Cap
12.73M
Enterprise Value
-3.37M
1-Year Change
-68.22%
Ranking
Category
Stock Price
$1.37
Market Cap Chart
Since February 9, 2021, SAB Biotherapeutics's market cap has decreased from $130.75M to $12.73M, a decrease of -90.27%. That is a compound annual growth rate of -42.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2025 | 12.08M | -65.52% |
| Dec 31, 2024 | 35.02M | -44.79% |
| Dec 29, 2023 | 63.43M | 113.36% |
| Dec 30, 2022 | 29.73M | -91.24% |
| Dec 31, 2021 | 339.54M | 159.68% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 740.84B |
| UnitedHealth Group | 386.83B |
| Johnson & Johnson | 378.90B |
| AbbVie | 306.60B |
| Novo Nordisk | 266.18B |
| Abbott Laboratories | 228.18B |
| AstraZeneca | 210.34B |
| Novartis AG | 209.93B |